Design, synthesis, molecular modeling, and biological evaluation of acrylamide derivatives as potent inhibitors of human dihydroorotate dehydrogenase for the treatment of rheumatoid arthritis
Human dihydroorotate dehydrogenase (DHODH) is a viable target for the development of therapeutics to treat cancer and immunological diseases, such as rheumatoid arthritis (RA), psoriasis and multiple sclerosis (MS). Herein, a series of acrylamide-based novel DHODH inhibitors as potential RA treatmen...
Saved in:
Main Authors: | Fanxun Zeng (Author), Shiliang Li (Author), Guantian Yang (Author), Yating Luo (Author), Tiantian Qi (Author), Yingfan Liang (Author), Tingyuan Yang (Author), Letian Zhang (Author), Rui Wang (Author), Lili Zhu (Author), Honglin Li (Author), Xiaoyong Xu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Purification and characterization of enzyme dihydroorotate dehydrogenase in plasmodium falciparum
by: Nattaprapa Suriyamontol
Published: (2013) -
SOX2-dependent expression of dihydroorotate dehydrogenase regulates oral squamous cell carcinoma cell proliferation
by: Xuemei Qiu, et al.
Published: (2021) -
Selective Cytotoxicity of Dihydroorotate Dehydrogenase Inhibitors to Human Cancer Cells Under Hypoxia and Nutrient-Deprived Conditions
by: Yukiko Miyazaki, et al.
Published: (2018) -
A pharmacokinetic drug-drug interaction study between rosuvastatin and emvododstat, a potent anti‐SARS‐CoV‐2 (COVID‐19) DHODH (dihydroorotate dehydrogenase) inhibitor
by: Terri L. Morton, et al.
Published: (2023) -
Pharmacokinetic predictions and docking studies of substituted aryl amine-based triazolopyrimidine designed inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH)
by: Zakari Ya'u Ibrahim, et al.
Published: (2021)